Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period

D Ao, X He, J Liu, L Xu - Signal Transduction and Targeted Therapy, 2023 - nature.com
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted
in significant casualties and put immense strain on public health systems worldwide, leading …

Recent advances in SARS-CoV-2 main protease inhibitors: from nirmatrelvir to future perspectives

A Citarella, A Dimasi, D Moi, D Passarella, A Scala… - Biomolecules, 2023 - mdpi.com
The main protease (Mpro) plays a pivotal role in the replication of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target …

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors

S Rampogu, TS Jung, MW Ha, KW Lee - Scientific Reports, 2023 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic that caused serious
global emergency. To identify new and effective therapeutics, we employed a drug …

Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …

Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A …

C Suhandi, SS Alfathonah, AN Hasanah - Molecules, 2023 - mdpi.com
ACE2 and Mpro in the pathology of SARS-CoV-2 show great potential in developing COVID-
19 drugs as therapeutic targets, due to their roles as the “gate” of viral entry and viral …

Complexation of Bromelain, Ficin, and Papain with the Graft Copolymer of Carboxymethyl Cellulose Sodium Salt and N-Vinylimidazole Enhances Enzyme Proteolytic …

AV Sorokin, SS Goncharova, MS Lavlinskaya… - International Journal of …, 2023 - mdpi.com
This study investigates the features of interactions between cysteine proteases (bromelain,
ficin, and papain) and a graft copolymer of carboxymethyl cellulose sodium salt with N …

Sweet Basil (Ocimum basilicum L.)―A Review of Its Botany, Phytochemistry, Pharmacological Activities, and Biotechnological Development

NS Azizah, B Irawan, J Kusmoro, W Safriansyah… - Plants, 2023 - mdpi.com
An urgent demand for natural compound alternatives to conventional medications has
arisen due to global health challenges, such as drug resistance and the adverse effects …

Green and efficient one-pot three-component synthesis of novel drug-like furo [2, 3-d] pyrimidines as potential active site inhibitors and putative allosteric hotspots …

H Mousavi, B Zeynizadeh, M Rimaz - Bioorganic Chemistry, 2023 - Elsevier
In this paper, an environmentally benign, convenient, and efficient one-pot three-component
reaction has been developed for the regioselective synthesis of novel 5-aroyl (or …

Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery

L Xu, R Chen, J Liu, TA Patterson, H Hong - Drug Discovery Today, 2023 - Elsevier
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) main protease has an
essential role in viral replication and has become a major target for coronavirus 2019 …

Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical …

YN Zhang, GH Zhu, W Liu, Y Xiong, Q Hu, XY Zhuang… - Phytomedicine, 2023 - Elsevier
Background The 3C-like proteases (3CL pro s) are cysteine-rich homodimeric proteins and
can be covalently modified by numerous natural and synthetic compounds, which in turn …